These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10458517)

  • 1. Chimeric peptide of Met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception.
    Gupta S; Pasha S; Gupta YK; Bhardwaj DK
    Peptides; 1999; 20(4):471-8. PubMed ID: 10458517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intracerebroventricularly administered chimeric peptide of metenkephalin and FMRFa--[D-Ala2]YFa-on antinociception and its modulation in mice.
    Gupta S; Pasha S; Gupta YK; Bhardwaj DK
    Brain Res Bull; 2001 May; 55(1):51-7. PubMed ID: 11427337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment.
    Vats ID; Dolt KS; Kumar K; Karar J; Nath M; Mohan A; Pasha MA; Pasha S
    J Neurosci Res; 2008 May; 86(7):1599-607. PubMed ID: 18183621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, conformational and pharmacological studies of glycosylated chimeric peptides of Met-enkephalin and FMRFa.
    Masand G; Hanif K; Sen S; Ahsan A; Maiti S; Pasha S
    Brain Res Bull; 2006 Jan; 68(5):329-34. PubMed ID: 16377439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
    Raffa RB; Connelly CD
    Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa.
    Gupta K; Vats ID; Gupta YK; Saleem K; Pasha S
    Peptides; 2008 Dec; 29(12):2266-75. PubMed ID: 18930087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationally designed chimeric peptide of met-enkephalin and FMRFa-[D-Ala2,p-Cl-Phe4]YFa induce multiple opioid receptors mediated antinociception and up-regulate their expression.
    Vats ID; Chaudhary S; Sharma A; Nath M; Pasha S
    Eur J Pharmacol; 2010 Jul; 638(1-3):54-60. PubMed ID: 20385120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[D-Ala2]YFa-on antinociception and opioid receptor regulation.
    Vats ID; Snehlata ; Nath M; Pasha MA; Pasha S
    Eur J Pain; 2010 Mar; 14(3):295.e1-9. PubMed ID: 19560378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tianeptine reduces morphine antinociceptive tolerance and physical dependence.
    Chu CC; Shieh JP; Shui HA; Chen JY; Hsing CH; Tzeng JI; Wang JJ; Ho ST
    Behav Pharmacol; 2010 Sep; 21(5-6):523-9. PubMed ID: 20679893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds.
    Gray AM; Spencer PS; Sewell RD
    Br J Pharmacol; 1998 Jun; 124(4):669-74. PubMed ID: 9690858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
    McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
    Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors.
    Shu H; Arita H; Hayashida M; Chiba S; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2006 Jun; 106(2):263-71. PubMed ID: 16446067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test.
    Shimoyama M; Shimoyama N; Inturrisi CE; Elliott KJ
    Pain; 1997 Sep; 72(3):375-82. PubMed ID: 9313278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel met-enkephalin analogue: a potent systemic mu agonist antinociceptive agent.
    Nath C; Patnaik GK; Haq W; Mathur KB; Srimal RC; Dhawan BN; Porreca F
    Pharmacol Res; 1995 May; 31(5):269-73. PubMed ID: 7479523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.